BioNTech SE (BNTX)
103.76
+0.88
(+0.86%)
USD |
NASDAQ |
Sep 04, 16:00
103.76
0.00 (0.00%)
After-Hours: 20:00
BioNTech SG&A Expense (TTM) : 833.57M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 833.57M |
| March 31, 2026 | 759.44M |
| December 31, 2025 | 709.95M |
| September 30, 2025 | 597.23M |
| June 30, 2025 | 589.02M |
| March 31, 2025 | 631.04M |
| December 31, 2024 | 648.03M |
| September 30, 2024 | 643.05M |
| June 30, 2024 | 650.58M |
| March 31, 2024 | 605.95M |
| December 31, 2023 | 603.23M |
| September 30, 2023 | 607.55M |
| June 30, 2023 | 589.53M |
| Date | Value |
|---|---|
| March 31, 2023 | 593.59M |
| December 31, 2022 | 570.29M |
| September 30, 2022 | 600.12M |
| June 30, 2022 | 538.05M |
| March 31, 2022 | 454.41M |
| December 31, 2021 | 393.84M |
| September 30, 2021 | 274.79M |
| June 30, 2021 | 214.27M |
| March 31, 2021 | 164.69M |
| December 31, 2020 | 125.32M |
| September 30, 2020 | 74.29M |
| June 30, 2020 | 42.04M |
| March 31, 2020 | 17.96M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Moderna, Inc. | 965.00M |
| Biodexa Pharmaceuticals Plc | 6.375M |
| NuCana Plc | 7.064M |
| Mereo BioPharma Group Plc | 19.44M |
| MediGene AG | -- |